587 When topical treatments are insufficient, Botulinum Toxin Type A injections into the affected areas inhibit acetylcholine release at neuromuscular junctions, resulting in a significant reduction in sweating for several months
Daily Facial Cleansing
Enhanced Muscle Growth Environment: By increasing both GH and IGF-1, tesamorelin creates a more anabolic environment
53 Finally, tirzepatide is a GLP1R/GIPR dual agonist, currently being evaluated in phase 3 trials
A study published in Annals of Internal Medicine examined how glucagon-like peptide-1 receptor agonists (GLP-1RAs, also known as GLP-1 drugs), sold under brand names such as Ozempic, affected depression risk compared to two other medications used in diabetes treatment
Reaching maintenance means your GLP-1 receptors have adapted to the medication, your hunger signals are durably reset, and your body has found its new metabolic equilibrium